News
BPTSY
1.380
NaN%
--
Weekly Report: what happened at BPTSY last week (0720-0724)?
Weekly Report · 2h ago
Weekly Report: what happened at BPTSY last week (0713-0717)?
Weekly Report · 07/20 09:27
Weekly Report: what happened at BPTSY last week (0706-0710)?
Weekly Report · 07/13 09:28
Weekly Report: what happened at BPTSY last week (0629-0703)?
Weekly Report · 07/06 09:29
Biophytis Posts Provisional 2025 Results as Trading Suspended Pending Audit
TipRanks · 07/01 16:57
Weekly Report: what happened at BPTSY last week (0622-0626)?
Weekly Report · 06/29 09:28
Weekly Report: what happened at BPTSY last week (0615-0619)?
Weekly Report · 06/22 09:31
Biophytis Halts Trading on Euronext After Delay in 2025 Annual Report
TipRanks · 06/16 14:00
Weekly Report: what happened at BPTSY last week (0608-0612)?
Weekly Report · 06/15 09:31
Biophytis Registers Hong Kong Joint Venture to Drive BIO101 Expansion in Asia
TipRanks · 06/09 15:57
Weekly Report: what happened at BPTSY last week (0601-0605)?
Weekly Report · 06/08 09:29
Biophytis Files Hong Kong Joint Venture Registration to Drive BIO101 Expansion in Asia
TipRanks · 06/02 14:49
Weekly Report: what happened at BPTSY last week (0525-0529)?
Weekly Report · 06/01 09:31
Biophytis Converts Hexagon Bond Line Into Cheaper €2m Revolving Facility to Back Phase 3 Sarcopenia Push
TipRanks · 05/28 15:58
Weekly Report: what happened at BPTSY last week (0518-0522)?
Weekly Report · 05/25 09:33
Weekly Report: what happened at BPTSY last week (0511-0515)?
Weekly Report · 05/18 09:33
Weekly Report: what happened at BPTSY last week (0504-0508)?
Weekly Report · 05/11 09:31
Weekly Report: what happened at BPTSY last week (0427-0501)?
Weekly Report · 05/04 09:30
Weekly Report: what happened at BPTSY last week (0420-0424)?
Weekly Report · 04/27 09:31
Weekly Report: what happened at BPTSY last week (0413-0417)?
Weekly Report · 04/20 09:30
More
Webull provides a variety of real-time BPTSY stock news. You can receive the latest news about Biophytis Sa through multiple platforms. This information may help you make smarter investment decisions.
About BPTSY
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.